Diagnostic HYBRIDS Lead Researcher Receives Prestigious Award From the National Academy of Clinical Biochemistry (Business Wire via Yahoo! Finance)
ATHENS, Ohio—-A team of researchers headed up by Diagnostic HYBRIDS′ Director of Monoclonal Antibody Product Development, Jimmy Page, Ph.D., and Mark Carle Connelly, Ph.D., Vice President of Reagent Development for Immunicon Corporation , has received the National Academy of Biochemistry’s Distinguished Abstract Award from the National Academy of Clinical Biochemistry for their abstract and …
Original post by Rachel